Very much a buy and hold from my point of view, yes it's been years but each year significant progress is being made.
Will be very interesting to see how the Italy & Middle East PD sales go come 2021, should the adoption be well received I think we will see some fund managers take notice and a very significant re-rate in anticipation for NAM penetration. The road PIQ has been down to commercialize PromarkerD has been long and arduous, any new entrant in this field will be faced with the same challenges, thus the progress we have made so far also serves as a barrier to entry for future competitors. We remain the worlds most accurate predictive diagnostic test for DKD.
The SP will take care of it self as we continue down this road. This is a not hype stock, I think many holders here are long term and understand the future returns on offer for patience. I remember the lull days of 24c-26c then we bumped up to 40-50c, I think the next leg will be 0.80-$1 all the way up to $10, provided PD becomes the gold standard.
Similar to no-vice, I too am continuing to buy and add to my position. (currently 160k shares) However will be watching closely, if the Italy penetration fails to deliver I will be re-thinking my sentiment.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)